Page last updated: 2024-09-04

febuxostat and Hepatitis

febuxostat has been researched along with Hepatitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abdelaziz, RR; Ibrahim, TM; Maresh, MM	1

Other Studies

1 other study(ies) available for febuxostat and Hepatitis

Article	Year
Febuxostat mitigates concanavalin A-induced acute liver injury via modulation of MCP-1, IL-1β, TNF-α, neutrophil infiltration, and apoptosis in mice. Life sciences, 2020, Nov-01, Volume: 260 Topics: Animals; Apoptosis; Caspase 3; Chemokine CCL2; Concanavalin A; Febuxostat; Hepatitis; Interleukin-1beta; Liver; Male; Mice; Neutrophil Infiltration; Neutrophils; Peroxidase; Tumor Necrosis Factor-alpha; Uric Acid	2020

Article

Year

Febuxostat mitigates concanavalin A-induced acute liver injury via modulation of MCP-1, IL-1β, TNF-α, neutrophil infiltration, and apoptosis in mice.

Life sciences, 2020, Nov-01, Volume: 260

Topics: Animals; Apoptosis; Caspase 3; Chemokine CCL2; Concanavalin A; Febuxostat; Hepatitis; Interleukin-1beta; Liver; Male; Mice; Neutrophil Infiltration; Neutrophils; Peroxidase; Tumor Necrosis Factor-alpha; Uric Acid

2020